Патентный пул лицензировал производство АРВ-препарата "Tenofovir Alafenamide" индийским фармкомпаниям
The UN's Medicines Patent Pool sub-licensed Gilead Sciences' investigational HIV therapy tenofovir alafenamide to five Indian drugmakers, livemint.com reported Thursday.
Under the agreement, Aurobindo, Cipla, Emcure Pharmaceuticals, Hetero and Laurus will be permitted ...